valproic acid and lysophosphatidylcholines

valproic acid has been researched along with lysophosphatidylcholines in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbas, C; Laje, G; Lorenzo, MP; Ramamoorthy, A; Silva dos Santos, M; VillaseƱor, A; Wainer, IW; Zarate, C1
Ghasemi-Kasman, M; Hashemian, M; Parsian, H; Sadeghi, F1

Trials

1 trial(s) available for valproic acid and lysophosphatidylcholines

ArticleYear
A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.
    British journal of pharmacology, 2014, Volume: 171, Issue:8

    Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Bipolar Disorder; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Ketamine; Lithium; Lysophosphatidylcholines; Lysophospholipids; Male; Metabolome; Middle Aged; Pilot Projects; Valproic Acid; Young Adult

2014

Other Studies

1 other study(ies) available for valproic acid and lysophosphatidylcholines

ArticleYear
Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm.
    Brain research bulletin, 2019, Volume: 153

    Topics: Animals; Demyelinating Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Histone Deacetylase 1; Lysophosphatidylcholines; Male; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Optic Chiasm; Rats; Rats, Wistar; Recovery of Function; Remyelination; Sphingosine-1-Phosphate Receptors; Valproic Acid

2019